entertainment -WSS

entertainment

author：entertainment 2025-10-02 00:43:30 - browse：4997

Doctors perform bariatric surgery at a hospital in Tijuana, Mexico. GUILLERMO ARIAS/AFP via Getty Images

Over the past year, weight loss drugs have captured the public’s imagination but also raised existential questions about the future of bariatric surgery.

For obesity, surgery has long been — and continues to be — the most effective treatment, reducing patients’ risk of sleep apnea, diabetes, cancer, cardiovascular disease, and death. However, the gap between weight loss drugs and bariatric surgery is starting to narrow after Wegovy cut the risk of major heart complications by 20% in Novo Nordisk’s SELECT trial.

“Personally, I would have taken a 5% reduction,” said Angela Fitch, president of the Obesity Medicine Association, emphasizing that these results symbolize a paradigm shift in obesity medicine. With even more effective weight loss drugs already emerging and other clinical trial evidence on the horizon, the hope is that, with medication, “we would see similar sorts of outcomes that we see with surgery,” said Fitch.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Microsoft's Peter Lee: Generative AI could help doctors be more human

WSS

Change Healthcare: What is it, why does its cyberattack matter?

For AI in health care standards, federal regulators join with industry group

Majority of Americans think Trump's Ga. election interference case is serious: POLL

Evacuations in place as 3 wildfires burn in eastern Washington state

Baltimore teen accused of firing into crowd during block party mass shooting

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

hotspot

entertainment

Wikipedia

Wildfire smoke exposes gaps in outdoor worker protections

ActiGraph execs on goal of drug approvals with digital endpoints

Alkermes shareholders re

Why Talkspace is targeting Medicare, a tricky market

After affirmative action ruling, medical educators look to 'holistic review'

Medicare drug price negotiation continues, as pharma counteroffers

Alkermes shareholders re

Cancer drug shortages' outsize impact on ovarian cancer patients

Medical leaders decry Supreme Court decision on affirmative action

Immune cells and nerve overgrowth may explain recurring UTI pain

explore

A neonatal nurse in a British hospital has been found guilty of killing 7 babies

New details revealed about Purdue's marketing of OxyContin

A new approach to psychiatric drug development

Evacuations in place as 3 wildfires burn in eastern Washington state

Stem cell biologist probes earliest stages of human development

State of the Union pitch: Bigger Medicare drug price negotiations

hotspot

entertainment

focus

entertainment